Manipulating nitrosative stress to kill pathologic microbes,...

Details Manipulating nitrosative stress to kill pathologic microbes,... Manipulating nitrosative stress to kill pathologic microbes,...

2006-04-04

2006-04-04

Weddington, Kevin E. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C514S561000, C514S562000

Reexamination Certificate

active

07022737

ABSTRACT:
Mammals are treated for infections or for conditions associated with pathologically proliferating mammalian cell growth by administration of a manipulator of nitrosative stress to selectively kill or reduce the growth of the microbes or helminths causing the infection or of host cells infected with the microbes or of the pathologically proliferating mammalian cells. Novel agents include α-alkyl-S-alkyl-homocysteine sulfoximines wherein the α-alkyl contains 2 to 8 carbon atoms, and the S-alkyl contains 1 to 10 carbon atoms. Mammals in need of increased nitrosative stress defenses are treated, e.g., humans at risk for a stroke because of having had a transient ischemic attack, are treated. Treatments to increase nitrosative stress defenses include repeated administrations of low doses of manipullators of nitrosative stress so that subject treated has increased tolerance to nitrosative stress. Mammals are treated for protozoal infections by systemic administration of L-buthionine-S-sulfoximine and agent that increases nirtrosative stress.

REFERENCES:
patent: 3968249 (1976-07-01), Bernstein et al.
patent: 4666835 (1987-05-01), Baldwin et al.
patent: 4834965 (1989-05-01), Martini et al.
patent: 4898878 (1990-02-01), Shapiro et al.
patent: 4927808 (1990-05-01), Kitahara et al.
patent: 4950651 (1990-08-01), Suli et al.
patent: 4966577 (1990-10-01), Crosson et al.
patent: 5112954 (1992-05-01), Abrams et al.
patent: 5196450 (1993-03-01), Sjoerdsma et al.
patent: 5286254 (1994-02-01), Shapland et al.
patent: 5290571 (1994-03-01), Bounous et al.
patent: 5294736 (1994-03-01), Griffith
patent: 5316767 (1994-05-01), Hara et al.
patent: 5342853 (1994-08-01), Mueller et al.
patent: 5362309 (1994-11-01), Carter
patent: 5385933 (1995-01-01), Rabinovitz et al.
patent: 5385937 (1995-01-01), Stamler et al.
patent: 5405919 (1995-04-01), Keefer et al.
patent: 5427797 (1995-06-01), Frostell et al.
patent: 5476966 (1995-12-01), Anderson et al.
patent: 5508045 (1996-04-01), Harrison et al.
patent: 5525357 (1996-06-01), Keefer et al.
patent: 5567592 (1996-10-01), Benet et al.
patent: 5578718 (1996-11-01), Cook et al.
patent: 5593876 (1997-01-01), Stamler et al.
patent: 5616775 (1997-04-01), Kronenthal
patent: 5628730 (1997-05-01), Shapland et al.
patent: 5639741 (1997-06-01), Witzel et al.
patent: 5641754 (1997-06-01), Iversen
patent: 5872104 (1999-02-01), Vermeulen et al.
patent: 5877185 (1999-03-01), Kun et al.
patent: 6011067 (2000-01-01), Hersh
patent: 6057367 (2000-05-01), Stamler et al.
patent: 6180824 (2001-01-01), Stamler et al.
patent: 6359004 (2002-03-01), Stamler et al.
patent: 6608110 (2003-08-01), Stamler et al.
patent: WO 89/09205 (1989-10-01), None
patent: WO 9616645 (1996-06-01), None
patent: WO 96/22791 (1996-08-01), None
Murphy et al., “Erythropoietin Alteration in Human Genitorinary Disease States: Correlation With Experimental Observations”, Journal of Urology, vol. 99, Issue No. 6, pp. 802-810 (Jun. 1968).
Crooke, S. T., Hematologic Pathology, 9(2), 59-72 (1995).
Bahr, N., et al., J. Am. Chem. Soc. 118, 3550-3555 (1996).
Feelisch, M. and Stamler, J. S., Chapter 7 from Methods in Nitric Oxide Research, Feelisch and Stamler, eds., John Wiley & Sons, New York, 1996.
Griffith, O. W., et al., J. Biol. Chem. 253, 2333-2338 (1978).
Griffith, O. W., et al., J. Biol. Chem. 254, 1205-1210 (1979).
Apontoweil, P., et al., Biochimica et Biophysica Acta 399, 10-22 (1975).
Han, J., et al. in “The Biology of Nitric Oxide Part 5 Proceedings of the 4th International Meeting on The Biology of Nitric Oxide,” Amelia Island, Florida, p. 114, Portland Press (Sep. 1995).
Hausladen, A., et al., Cell, vol. 86, 1-20 (Sep. 6, 1996).
Hirvonen, M-R, et al., Biochem. J. 315, 845-849 (1996).
Hamon, M., et al., Circulation, 90, 1357-1362 (1994).
DeGroote, M. A., et al., Science 272, 414-417 (Apr. 1996).
Pacelli, R., et al., Lancet, 347, 900 (1996).
Eskenazi, A. E., et al., J. Nat'l Cancer Instit., 85, 711-721 (May 1993).
Diaz Gomez, M. I., et al., Cancer Lett., 40, 257-263 (1988).
Alaoui-Jamali, M., et al., Cancer Chemo. Pharmacol., 34, 153-158 (1994).
Krauth-Siegel, R. L., et al., FASEB J., 9, 1138-1146 (1995).
Arrick, B. A., et al., J. Exp. Med. 153, 720-725 (1981).
Ramsay, et al., British Journal of Clinical Pathology 40, 101-102 (1995).
Mebmer, U.K., et al., FEBS Letters, 355, 23-26 (1994).
Andrew, P.J., et al., Biochem. Biophys. Res. Commun., 214, 949-956 (Sep. 25, 1995).
Held, K.D., et al., Mutation Research 299, 261-269 (1993).
Moore, W.K., et al., Proc. Nat'l Acl. Sci. USA, 86, 1461-1464 (Mar. 1989).
Guillemard, E., et al., Antimicrobial Agents and Chemotherapy, 1057-1059 (Apr. 1996).
Radomski, M. W., et al., Br. J. Pharmacol., 107, 745-749 (1992).
Bogle, R. G., et al., Br. J. Pharmacol., 105, 768-770 (1992).
deBelder, A., et al., The Lancet, 345, 124-125 (Jan. 1995).
Young, D. B., et al., Annual Review of Microbiology, 49, 641-673 (1995).
Singh, R. J., et al., J. Biol. Chem., 271, 18596-18603 (Aug. 1996).
Struck, A. J., et al., FEBS Letters, 361, 291-294 (1995).
Wang, T., et al., Cellular Pharmacology, vol. 2, 237-240 (1995).
Yi-zun, J., et al., Chinese Medical Journal, 105, 647-650 (1992).
Wink, D. A., et al., J. Biol. Chem. 272, 11147-11151 (Apr. 1997).
Hausladen, A., et al., Cell., 86, 719-726 (Sep. 6, 1996).
Nathan, Carl F., et al., Immunology 3, 65-70 (1991).
Weckbecker, G., et al., Cancer Letters, 40, 257-264 (1988).
Eskenazi, A. E., et al., JNCI, 85, No. 9, 711-721 (May 5, 1993).

Affiliated with

Also associated with

Rating

Manipulating nitrosative stress to kill pathologic microbes,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Manipulating nitrosative stress to kill pathologic microbes,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Manipulating nitrosative stress to kill pathologic microbes,... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3553736